EUVIMEDEUVIMED entdecken
Netzwerk-Metaanalyse

Comparative efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in preclinical renal ischemia-reperfusion injury models: Multilevel and network meta-analyses

Selda Emre Aydıngöz, Ariyan Teimoori, Murat Koçak

Journal of the Renin-Angiotensin-Aldosterone System · 2026-03 · 27

DOI: 10.1177/14703203261430477 ↗

Kurz gefasst

Netzwerk-Metaanalyse in der Zeitschrift Journal of the Renin-Angiotensin-Aldosterone System, online erschienen am 11.03.2026. Verfasst von Selda Emre Aydıngöz und 2 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Başkent University Research Fund.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypothesis/Introduction The renin-angiotensin system plays a central role in renal ischemia-reperfusion injury (IRI). We evaluated the effects of angiotensin-converting enzyme inhibitors (ACEIs) and AT1 receptor blockers (ARBs) in preclinical renal IRI models using multilevel and network meta-analyses (PROSPERO: CRD42024599859). Materials and Methods Database searches identified 55 studies. Serum creatinine data were pooled using three-level random-effects models (96 comparisons, n = 1233 animals). Publication bias was assessed using Egger and 1/√n methods. Drugs were ranked via P-scores.

Results

ACEIs/ARBs significantly reduced creatinine (standardized mean difference: −1.74; 95% CI: −2.22 to −1.26; p < 0.0001) with high heterogeneity. Egger's test showed asymmetry ( p < 0.0001), but 1/√n-based testing did not ( p = 0.160), suggesting mathematical artifact rather than publication bias. Multivariable meta-regression identified drug identity, dose, and route as key effect modifiers. Network analysis ranked azilsartan and telmisartan highest, though evidence remains limited (no direct comparisons, n = 2 for azilsartan). Secondary outcomes confirmed renal protection.

Conclusions

ACEIs/ARBs effectively reduce renal IRI in animals, with azilsartan and telmisartan ranking favorably despite limited evidence. High-dose intravenous administration enhances efficacy. Most studies used pre-ischemia protocols relevant only to transplantation. Post-injury models with comorbid animals of both sexes and direct drug comparisons are needed for clinical translation.

Förderung

  • Başkent University Research Fund

Zitieren

APA

Aydıngöz, S. E., Teimoori, A., & Koçak, M. (2026). Comparative efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in preclinical renal ischemia-reperfusion injury models: Multilevel and network meta-analyses. Journal of the Renin-Angiotensin-Aldosterone System, 27. https://doi.org/10.1177/14703203261430477

Vancouver

Aydıngöz SE, Teimoori A, Koçak M. Comparative efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in preclinical renal ischemia-reperfusion injury models: Multilevel and network meta-analyses. Journal of the Renin-Angiotensin-Aldosterone System. 2026;27. doi:10.1177/14703203261430477

BibTeX
@article{Aydngz2026,
  author = {Aydıngöz, Selda Emre and Teimoori, Ariyan and Koçak, Murat},
  title = {Comparative efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in preclinical renal ischemia-reperfusion injury models: Multilevel and network meta-analyses},
  journal = {Journal of the Renin-Angiotensin-Aldosterone System},
  year = {2026},
  volume = {27},
  doi = {10.1177/14703203261430477}
}
Kostenlos starten →